Uterine myomas and sarcomas – clinical and ultrasound characteristics and differential diagnosis using pulsed and color Doppler techniques

1Van den Bosch T, Coosemans A, Morina M, Timmerman D, Amant F: Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol 2012; 26: 257–266.Vanden Bosch TCoosemansAMorinaMTimmermanDAmantFScreening for uterine tumoursBest Pract Res Clin Obstet Gynaecol20122625726610.1016/j.bpobgyn.2011.08.002Search in Google Scholar

2Divakar H: Asymptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22: 643–654.DivakarHAsymptomatic uterine fibroidsBest Pract Res Clin Obstet Gynaecol20082264365410.1016/j.bpobgyn.2008.01.007Search in Google Scholar

3Duhan N, Sirohiwal D: Uterine myomas revisited. Eur J Obstet Gynaecol Reprod Biol 2010; 152: 119–125.DuhanNSirohiwalDUterine myomas revisitedEur J Obstet Gynaecol Reprod Biol201015211912510.1016/j.ejogrb.2010.05.010Search in Google Scholar

4Wallach EE, Vhahos NF: Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004; 104: 393–406.WallachEEVhahosNFUterine myomas: an overview of development, clinical features, and managementObstet Gynecol200410439340610.1097/01.AOG.0000136079.62513.39Search in Google Scholar

5Woźniak S, Pietrzak B, Paszkowski T, Radowicki S, Pawelczyk L, Wielgoś M: Farmakoterapia mięśniaków macicy. Ginekologia i Perinatologia Praktyczna 2017; 2: 43–47.WoźniakSPietrzakBPaszkowskiTRadowickiSPawelczykLWielgośMFarmakoterapia mięśniaków macicyGinekologia i Perinatologia Praktyczna201724347Search in Google Scholar

6Baranowski W, Piechota E: Etiopatogeneza mięśniaków macicy. Gine-kologia po Dyplomie 2006; 9: 4–8.BaranowskiWPiechotaEEtiopatogeneza mięśniaków macicyGine-kologia po Dyplomie2006948Search in Google Scholar

7Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ et al.: MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 2011; 334: 252–255.MäkinenNMehineMTolvanenJKaasinenELiYLehtonenHJet alMED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomasScience201133425225510.1126/science.1208930Search in Google Scholar

8Mehine M, Kaasinen E, Heinonen HR, Mäkinen N, Kämpjärvi K, Sarvilinna et al.: Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci USA 2016; 113: 1315–1320.MehineMKaasinenEHeinonenHRMäkinenNKämpjärviKSarvilinna et alIntegrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkersProc Natl Acad Sci USA20161131315132010.1073/pnas.1518752113Search in Google Scholar

9Tallini G, Dal Cin P: HMGI(Y) and HMGI-C dysregulation: a common occurence in human tumors. Adv Anat Pathol 1999; 6: 237–246.TalliniGDalCin PHMGI(Y) and HMGI-C dysregulation: a common occurence in human tumorsAdv Anat Pathol1999623724610.1097/00125480-199909000-00001Search in Google Scholar

10Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P et al.: HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatibile with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 2000; 80: 359–369.TalliniGVanniRManfiolettiGKazmierczakBFaaGPauwelsPet alHMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatibile with rearrangement of the HMGI-C and HMGI(Y) genesLab Invest20008035936910.1038/labinvest.3780040Search in Google Scholar

11Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP et al.: Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003; 12: 1241–1252.AlamNARowanAJWorthamNCPollardPJMitchellMTyrerJPet alGenetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis and renal cancer, and fumarate hydratase deficiencyHum Mol Genet2003121241125210.1093/hmg/ddg148Search in Google Scholar

12Alam NA, Olpin S, Rowan A, Kelsell D, Leigh IM, Tomlinson IPM et al.: Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn 2005; 7: 437–443.AlamNAOlpinSRowanAKelsellDLeighIMTomlinsonIPMet alMissense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancerJ Mol Diagn2005743744310.1016/S1525-1578(10)60574-0Search in Google Scholar

13Parker WP: Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007; 87: 725–736.ParkerWPEtiology, symptomatology, and diagnosis of uterine myomasFertil Steril20078772573610.1016/j.fertnstert.2007.01.093Search in Google Scholar

14Valladares F, Frias I, Báez D, García C, Lopez F, Fraser J et al.: Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells. Fertil Steril 2006; 86: 1736–1743.ValladaresFFriasIBáezDGarcíaCLopezFFraserJet alCharacterization of estrogen receptors alpha and beta in uterine leiomyoma cellsFertil Steril2006861736174310.1016/j.fertnstert.2006.05.047Search in Google Scholar

15Koshiyama M, Okamoto T, Ueta M: The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis external and myoma uteri. Cancer Epidemiol 2004; 28: 94–98.KoshiyamaMOkamotoTUetaMThe relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis external and myoma uteriCancer Epidemiol200428949810.1016/j.cdp.2003.12.008Search in Google Scholar

16Drosdzol- Cop A., Wilk K: Rola witaminy D w położnictwie i ginekologii. Forum Położn Ginekol 2018; 43.Drosdzol-Cop A.WilkKRola witaminy D w położnictwie i ginekologii. Forum Położn Ginekol201843Search in Google Scholar

17Todorović A , Pejić S, Gavrilović L, Pavlović I , Stojiljković V, Popović N et al.: Expression of antioxidant enzymes in patients with uterine polyp, myoma, hyperplasia, and adenocarcinoma. Antioxidants 2019; 8: 97.TodorovićAPejićSGavrilovićLPavlovićIStojiljkovićVPopovićNet alExpression of antioxidant enzymes in patients with uterine polyp, myoma, hyperplasia, and adenocarcinomaAntioxidants201989710.3390/antiox8040097Search in Google Scholar

18Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, Jones ES et al.: The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol 2008; 198: 168.e1–168.e9.HuyckKLPanhuysenCICuencoKTZhangJGoldhammerHJonesESet alThe impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sistersAm J Obstet Gynecol2008198168e1–168.e910.1016/j.ajog.2007.05.038Search in Google Scholar

19Donnez J, Jadoul P: What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002; 17: 1424–1430.DonnezJJadoulPWhat are the implications of myomas on fertility?A need for a debate? Hum Reprod2002171424143010.1093/humrep/17.6.1424Search in Google Scholar

20Campo S, Campo V, Gambadauro P: Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas. Eur J Obstet Gynecol Reprod Biol 2003; 110: 215–219.CampoSCampoVGambadauroPReproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomasEur J Obstet Gynecol Reprod Biol200311021521910.1016/S0301-2115(03)00159-3Search in Google Scholar

21Alcazar JL, Griffioen M, Jurado M: Uterine artery blood flow in women with uterine myomas. Eur J Ultrasound 1997; 5: 165–169.AlcazarJLGriffioenMJuradoMUterine artery blood flow in women with uterine myomasEur J Ultrasound1997516516910.1016/S0929-8266(97)00016-5Search in Google Scholar

22Czekierdowski A, Bednarek W, Kotarski J: Rola współczesnej ultrasonografii w diagnostyce i leczeniu kobiet z mięśniakami macicy. Ginekol Dypl 2006; 9: 15–25.CzekierdowskiABednarekWKotarskiJRola współczesnej ultrasonografii w diagnostyce i leczeniu kobiet z mięśniakami macicyGinekol Dypl200691525Search in Google Scholar

23Suren A, Osmers R, Kuhn W: 3D Color Power Angio imaging: a new method to assess intracervical vascularization in benign and pathological conditions. 1998; 11: 133–137.SurenAOsmersRKuhnW3D Color Power Angio imaging: a new method to assess intracervical vascularization in benign and pathological conditions19981113313710.1046/j.1469-0705.1998.11020133.x9549841Search in Google Scholar

24Deane C: Placing value on pictureswhat information is there in color flow images and how can we use it? Ultrasound Obstet Gynecol 2001; 17: 189–190.DeaneCPlacing value on pictureswhat information is there in color flow images and how can we use it?Ultrasound Obstet Gynecol20011718919010.1046/j.1469-0705.2001.00400.x11309165Search in Google Scholar

25Valentin L: Use of colour and spectral Doppler ultrasound examination in gynecology. Eur J Ultrasound 1997; 6: 143–163.ValentinLUse of colour and spectral Doppler ultrasound examination in gynecologyEur J Ultrasound1997614316310.1016/S0929-8266(97)10023-4Search in Google Scholar

26Van den Bosch T, Dueholm M, Leone FP, Valentin L, Rasmussen CK, Votino A et al.: Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol 2015; 46: 284–298.Vanden Bosch TDueholmMLeoneFPValentinLRasmussenCKVotinoAet alTerms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) groupUltrasound Obstet Gynecol20154628429810.1002/uog.14806Search in Google Scholar

27Shah JP, Bryant CS, Kumar S, Ali-Fehmi R, Malone Jr JM, Morris RT: Lymphadenectomy and ovarian presentation in low-grade endometrial stromal sarcoma. Obstet Gynecol 2008; 112: 1102–1108.ShahJPBryantCSKumarSAli-FehmiRMaloneJr JMMorrisRTLymphadenectomy and ovarian presentation in low-grade endometrial stromal sarcomaObstet Gynecol20081121102110810.1097/AOG.0b013e31818aa89aSearch in Google Scholar

28McLucas B: Diagnosis, imaging and anatomical classification of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22: 627–642.McLucasBDiagnosis, imaging and anatomical classification of uterine fibroidsBest Pract Res Clin Obstet Gynaecol20082262764210.1016/j.bpobgyn.2008.01.006Search in Google Scholar

29Sosić A, Skupski DW, Streltzoff J, Yun H, Chervenak FA: Vascularity of uterine myomas: assessment by color and pulsed Doppler ultrasound. Int J Gynecol Obstet 1996; 54: 245–250.SosićASkupskiDWStreltzoffJYunHChervenakFAVascularity of uterine myomas: assessment by color and pulsed Doppler ultrasoundInt J Gynecol Obstet19965424525010.1016/0020-7292(96)02722-1Search in Google Scholar

30Johari B, Koshy M, Sidek S, Hanafiah M: Lipoleiomyoma: a rare benign tumour of the uterus. BMJ Case Rep 2014; bcr2014205814.JohariBKoshyMSidekSHanafiahMLipoleiomyoma: a rare benign tumour of the uterusBMJ Case Rep2014bcr201420581410.1136/bcr-2014-205814420812525331147Search in Google Scholar

31Exacoustos C, Romanini ME, Amadio A, Amorosso C, Szabolcs B, Zupi E et al.: Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma? J Clin Ultrasound 2007; 35: 449–457.ExacoustosCRomaniniMEAmadioAAmorossoCSzabolcsBZupiEet alCan gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?J Clin Ultrasound20073544945710.1002/jcu.2038617636502Search in Google Scholar

32Exacoustos C, Manganaro L, Zupi E: Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol 2014; 28: 655–681.ExacoustosCManganaroLZupiEImaging for the evaluation of endometriosis and adenomyosisBest Pract Res Clin Obstet Gynaecol20142865568110.1016/j.bpobgyn.2014.04.01024861247Search in Google Scholar

33Kurjak A, Kupesic S, Shalan H, Jukic S, Kosuta D, Ilijas M: Uterine sarcoma: a report of 10 cases studiem by transvaginal color and pulsed Doppler sonography. Gynecol Oncol 1995; 59: 342–346.KurjakAKupesicSShalanHJukicSKosutaDIlijasMUterine sarcoma: a report of 10 cases studiem by transvaginal color and pulsed Doppler sonographyGynecol Oncol19955934234610.1006/gyno.1995.99658522252Search in Google Scholar

34Ambrosio M, Raimondo D, Savelli L, Salucci P, Arena A, Borghese G et al.: Transvaginal ultrasound and Doppler features of intraligamental myomas. J Ultrasound Med 2020; 39: 1253–1259.AmbrosioMRaimondoDSavelliLSalucciPArenaABorgheseGet alTransvaginal ultrasound and Doppler features of intraligamental myomasJ Ultrasound Med2020391253125910.1002/jum.1521331944342Search in Google Scholar

35Markowska J, Mądro R: Zarys ginekologii onkologicznej, t. 1–2, wyd. 3; 2018.MarkowskaJMądroRZarys ginekologii onkologicznej, t. 1–2, wyd. 3;2018Search in Google Scholar

36Denschlag D, Ulrich UA: Uterine carcinosarcomas – diagnosis and management. Oncol Res Treat 2018; 41: 675–679.DenschlagDUlrichUAUterine carcinosarcomas – diagnosis and managementOncol Res Treat20184167567910.1159/00049433530317231Search in Google Scholar

37Wu T, Yen T-C, Lai C-H: Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 2011; 25: 681–689.WuTYenT-CLaiC-HClinical presentation and diagnosis of uterine sarcoma, including imagingBest Pract Res Clin Obstet Gynaecol20112568168910.1016/j.bpobgyn.2011.07.00221816678Search in Google Scholar

38Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009; 104: 177–178.PratJFIGO staging for uterine sarcomasInt J Gynaecol Obstet200910417717810.1016/j.ijgo.2008.12.00819135669Search in Google Scholar

39FIGO Committee on Gynecologic Oncology. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009; 104: 179.FIGO Committee on Gynecologic Oncology. FIGO staging for uterine sarcomasInt J Gynaecol Obstet200910417910.1016/j.ijgo.2008.12.009Search in Google Scholar